IL6 and cancer: There is robust evidence that several inflammatory mediators such as tumor necrosis factor (TNF-α), interleukin (IL)-6, IL-10, transforming growth factor β (TGF-β), and high-sensitivity c-reactive protein (hs-CRP) are critical components of oxidative DNA damage, triggering malignant tumor progression [6,9,10].